共 50 条
- [23] Mineralocorticoid receptor antagonists in diabetic kidney disease — mechanistic and therapeutic effects Nature Reviews Nephrology, 2022, 18 : 56 - 70
- [25] Renoprotective Effects of Mineralocorticoid Receptor Antagonists Against Diabetic Kidney Disease ADVANCED BIOLOGY, 2024, 8 (03):
- [26] Is there a new dawn for selective mineralocorticoid receptor antagonism? CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2014, 23 (05): : 456 - 461
- [27] Mineralocorticoid Receptor Antagonism in AKI: A New Hope? JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2016, 27 (02): : 335 - 337
- [28] Finerenone: A Non-steroidal Mineralocorticoid Receptor Blocker for Diabetic Kidney Disease TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2021, 32 (05): : 261 - 263
- [29] The novel mineralocorticoid receptor antagonist finerenone in diabetic kidney disease: Progress and challenges METABOLISM-CLINICAL AND EXPERIMENTAL, 2016, 65 (09): : 1342 - 1349